#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Familial amyotrophic lateral sclerosis Retinopathy of prematurity Eosinophilic oesophagitis Dermatitis Phenylketonuria Hypochondroplasia Complex regional pain syndrome Chronic cutaneous lupus erythematosus Hepatocellular carcinoma Graft versus host disease Anal squamous cell carcinoma Plasma cell myeloma Biliary neoplasm Pleomorphic leiomyosarcoma Narcolepsy More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent – Trials in Disease Mucous membrane pemphigoid – Life with Disease Primary biliary cholangitis – Life with Disease Gastrointestinal stromal tumour – Trials in Disease SAPHO syndrome – Basic Information Methylmalonic acidaemia Acquired haemophilia – Diagnostics Cholangitis sclerosing – Diagnostics Progressive multifocal leukoencephalopathy – Treatment Marginal zone lymphoma refractory – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Golexanolone Ladarixin Sapropterin Dihydrochloride Sotalol Hydrochloride HRS 9531 Donepezil BRENSOCATIB Erenumab Treg02 Macrogol 4000 VOTOPLAM Xenon Mannitol Betahistine Dihydrochloride Oxacillin Sodium Ascorbate Nmd670 Clemastine Fumarate Fipaxalparant Acetylsalicylic Acid Ph. Eur. More therapies…

    Learn about Your Condition

    Cardiogenic shock Oesophageal atresia Gastrointestinal melanoma Fallopian tube cancer Ewing's sarcoma metastatic Diminished ovarian reserve Pneumothorax Systemic sclerosis pulmonary Anal cancer Thromboembolectomy Toxic epidermal necrolysis T-cell type acute leukaemia Transitional cell carcinoma Colorectal cancer stage II Peritoneal cancer index More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Cenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cenegermin
    • Oxybuprocaine Hydrochloride
    • Tetracaine Hydrochloride
    Czechia France Germany Hungary Italy The Netherlands +2

  • A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes

    Recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    • Overweight
    Croatia Hungary Italy Romania Slovakia

  • KAI-9531 in Adults With Obesity or Overweight and Diabetes

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • HRS 9531
    Bulgaria Czechia Germany Hungary Poland Spain

  • FWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Bulgaria Czechia France Germany Hungary Italy +3

  • High-Dose Colecalciferol for 28-Day Mortality in Critically Ill Adults with Severe Vitamin D Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    • Vitamin D deficiency
    • Critical illness
    Investigated Drugs:
    • Colecalciferol
    Austria Germany

  • Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Belzutifan
    Czechia Denmark France Germany Greece Italy +3
Previous Page
1 … 19 20 21 22 23 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!